Magnesium and Sleep: An Evidence Summary

Overview

Magnesium status is closely linked to sleep quality across various populations. Research indicates that both low dietary intake and low serum magnesium levels are associated with poor sleep outcomes in adults (PMID: 35184264, PMID: 41515231).

Mechanism of Action

Based on available clinical evidence, magnesium supplementation appears to influence sleep by reducing inflammatory and physiological stress markers. Specifically, supplementation has been shown to reduce C-reactive protein (CRP) and cortisol levels (PMID: 21199787), as well as reduce psychological stress as measured by the DASS-42 scale (PMID: 35631229).

Evidence by Study Type

Meta-Analyses & Systematic Reviews * A systematic review of studies involving 7,582 participants found significant associations between low magnesium status and poor sleep quality in adults (PMID: 35184264). * A meta-analysis investigating magnesium supplementation for insomnia in older adults found a modest improvement in sleep quality scores, though the findings were limited by small study sizes (PMID: 33865376).

Randomized Controlled Trials (RCTs) * In a double-blind, placebo-controlled study of 155 adults with poor sleep, 250mg of elemental magnesium per day in the form of magnesium bisglycinate significantly improved Insomnia Severity Index (ISI) scores (PMID: 40918053). * In trained males experiencing partial sleep deprivation, the use of Zinc magnesium aspartate (ZMA) improved self-reported sleep quality compared to a placebo (PMID: 38257144). * In a study of 100 adults over age 51 with poor sleep, magnesium supplementation improved magnesium status indicators and reduced inflammatory stress markers, including CRP and cortisol (PMID: 21199787). * In patients with fibromyalgia, 100mg/day of magnesium chloride for one month reduced stress (DASS-42) and improved sleep-related symptoms (PMID: 35631229).

Observational Studies * A cross-sectional study of 1,041 Saudi adults found that both serum and dietary magnesium levels were positively associated with Pittsburgh Sleep Quality Index (PSQI) scores (PMID: 41515231).

Key Findings

  • Association with Low Status: Low dietary and serum magnesium levels are linked to poor sleep quality (PMID: 35184264, PMID: 41515231).
  • Improved Sleep Scores: Magnesium supplementation has been shown to improve ISI scores in adults with poor sleep (PMID: 40918053) and sleep quality in older adults with insomnia (PMID: 33865376).
  • Stress Reduction: Magnesium may reduce physiological stress markers (cortisol and CRP) and psychological stress (PMID: 21199787, PMID: 35631229).
  • Resilience to Deprivation: ZMA may help maintain self-reported sleep quality during periods of sleep restriction (PMID: 38257144).

Dosing Insights

The following doses and forms were studied in the clinical literature: * Magnesium bisglycinate: 250mg elemental magnesium per day (PMID: 40918053). * Magnesium chloride: 100mg per day (PMID: 35631229). * Zinc magnesium aspartate (ZMA): Studied for use during sleep deprivation (PMID: 38257144).

Safety & Limitations

Current meta-analyses regarding magnesium for insomnia in older adults are limited by small study sizes (PMID: 33865376).

Bottom Line

Magnesium supplementation shows promise in improving sleep quality and reducing stress-related markers across various groups, including older adults and those with fibromyalgia. However, the strength of meta-analytic conclusions is currently limited by the small size of the underlying studies.